ScinoPharm Taiwan Ltd Cash Flow Conversion Efficiency

Latest as of March 2026: 0.019x

ScinoPharm Taiwan Ltd cash flow conversion efficiency. Based on the latest financial reports, ScinoPharm Taiwan Ltd (1789) has a cash flow conversion efficiency ratio of 0.019x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$199.47 Million ≈ $6.28 Million USD) by net assets (NT$10.31 Billion ≈ $324.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of ScinoPharm Taiwan Ltd (2007–2025)

Cash flow conversion efficiency of ScinoPharm Taiwan Ltd from 2007 to 2025. This chart illustrates how ScinoPharm Taiwan Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ScinoPharm Taiwan Ltd (1789) stock price for real-time trading data and today's change.

ScinoPharm Taiwan Ltd Cash Flow Conversion Ratio Explained

ScinoPharm Taiwan Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

ScinoPharm Taiwan Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ScinoPharm Taiwan Ltd ranked by their cash flow conversion efficiency. Also see ScinoPharm Taiwan Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Soulbrain Holdings Co. Ltd KQ:036830	0.005x
PNE AG XETRA:PNE3	-0.170x
Sprout Social Inc NASDAQ:SPT	0.117x
Taiwan Chinsan Electronic Industrial Co Ltd TWO:8042	0.042x
Medigen Vaccine Biologics TWO:6547	-0.026x
BOKU INC. REG S DL-0001 F:B04	N/A
Sinosun Tech SHE:300333	-0.011x
Europower Enerji ve Otomasyon Teknolojileri Sanayi Ticaret A.S. IS:EUPWR	-0.023x

Annual Cash Flow Conversion Efficiency for ScinoPharm Taiwan Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of ScinoPharm Taiwan Ltd from 2007 to 2025. Review ScinoPharm Taiwan Ltd (1789) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$10.52 Billion ≈ $331.59 Million	NT$597.11 Million ≈ $18.81 Million	0.057x	-20.47%
2024-12-31	NT$10.53 Billion ≈ $331.62 Million	NT$750.91 Million ≈ $23.66 Million	0.071x	+219.91%
2023-12-31	NT$10.36 Billion ≈ $326.54 Million	NT$231.13 Million ≈ $7.28 Million	0.022x	-69.88%
2022-12-31	NT$10.45 Billion ≈ $329.23 Million	NT$773.79 Million ≈ $24.38 Million	0.074x	+52.66%
2021-12-31	NT$10.51 Billion ≈ $331.16 Million	NT$509.82 Million ≈ $16.06 Million	0.049x	-46.03%
2020-12-31	NT$10.53 Billion ≈ $331.73 Million	NT$946.31 Million ≈ $29.81 Million	0.090x	+16.88%
2019-12-31	NT$10.26 Billion ≈ $323.24 Million	NT$788.95 Million ≈ $24.86 Million	0.077x	-34.20%
2018-12-31	NT$10.54 Billion ≈ $332.04 Million	NT$1.23 Billion ≈ $38.80 Million	0.117x	+25.28%
2017-12-31	NT$10.42 Billion ≈ $328.20 Million	NT$971.71 Million ≈ $30.61 Million	0.093x	-42.70%
2016-12-31	NT$10.23 Billion ≈ $322.23 Million	NT$1.67 Billion ≈ $52.46 Million	0.163x	+53.63%
2015-12-31	NT$9.86 Billion ≈ $310.55 Million	NT$1.04 Billion ≈ $32.91 Million	0.106x	+11.90%
2014-12-31	NT$9.38 Billion ≈ $295.53 Million	NT$888.29 Million ≈ $27.99 Million	0.095x	-2.80%
2013-12-31	NT$9.64 Billion ≈ $303.82 Million	NT$939.47 Million ≈ $29.60 Million	0.097x	-9.97%
2012-12-31	NT$9.07 Billion ≈ $285.78 Million	NT$981.55 Million ≈ $30.92 Million	0.108x	-28.44%
2011-12-31	NT$8.56 Billion ≈ $269.67 Million	NT$1.29 Billion ≈ $40.78 Million	0.151x	-35.46%
2010-12-31	NT$6.68 Billion ≈ $210.37 Million	NT$1.56 Billion ≈ $49.29 Million	0.234x	-19.27%
2009-12-31	NT$4.47 Billion ≈ $140.89 Million	NT$1.30 Billion ≈ $40.89 Million	0.290x	-29.06%
2008-12-31	NT$3.44 Billion ≈ $108.39 Million	NT$1.41 Billion ≈ $44.34 Million	0.409x	+105.43%
2007-12-31	NT$2.53 Billion ≈ $79.82 Million	NT$504.50 Million ≈ $15.89 Million	0.199x	--

About ScinoPharm Taiwan Ltd

TW:1789 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$493.27 Million

NT$15.66 Billion TWD

Market Cap Rank

#11933 Global

#438 in Taiwan

Share Price

NT$19.80

Change (1 day)

-2.46%

52-Week Range

NT$16.75 - NT$28.25

All Time High

NT$55.57